Gold Price Analysis: XAU/USD fades Friday’s recovery above $1,850 despite vaccine hopes
Gold prices remain depressed near $1,870, down 0.10% intraday, during the early Monday morning in Asia. In doing so, the yellow metal fails to extend Friday’s bounce off $1,852.80 to near $1,880. The reason could be traced to the traders’ confusion amid mixed clues concerning the coronavirus (COVID-19) and vaccines as well as a lack of confirmation on the Brexit deal and the tussle between the US Fed and Treasury.
|Today last price||1871.42|
|Today Daily Change||-1.53|
|Today Daily Change %||-0.08|
|Today daily open||1872.95|
|Previous Daily High||1879.85|
|Previous Daily Low||1860.94|
|Previous Weekly High||1899.14|
|Previous Weekly Low||1852.8|
|Previous Monthly High||1933.3|
|Previous Monthly Low||1860|
|Daily Fibonacci 38.2%||1872.63|
|Daily Fibonacci 61.8%||1868.16|
|Daily Pivot Point S1||1862.64|
|Daily Pivot Point S2||1852.34|
|Daily Pivot Point S3||1843.73|
|Daily Pivot Point R1||1881.55|
|Daily Pivot Point R2||1890.16|
|Daily Pivot Point R3||1900.46|
Gold Weekly Forecast: Coronavirus vaccine optimism hurts XAU/USD
After failing to break above $1,900 at the start of the week, Gold spent the majority of the week under modest bearish pressure and dropped to $1,850 area before staging a rebound on Friday. Nevertheless, XAU/USD closed the second straight week in the negative territory around $1,870.
The upbeat Industrial Production and Retail Sales data from China revived hopes for a steady global economic recovery and provided a boost to market sentiment at the start of the week. Additionally, Moderna announced that its coronavirus vaccine candidate was 94.5% effective in the latest trials and noted that it will be seeking authorization for emergency use of the vaccine in the US in the coming weeks.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.